Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...

Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...

Orforglipron carried more side effects, however ...

Novo Nordisk (NVO) stock is in focus as the company teams up with Vivtex in a $2.1B deal to develop next-gen oral biologics for obesity and diabetes. Read more here.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

The FDA approves the Allurion balloon for weight loss, which is swallowed and doesn't require a procedure for removal. Doctors explain how it works.